

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 8.44635307 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 8.44635307 |
| 3 | endocrine pancreas development (GO:0031018) | 7.05494087 |
| 4 | signal peptide processing (GO:0006465) | 6.29568747 |
| 5 | immunoglobulin mediated immune response (GO:0016064) | 5.77932460 |
| 6 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.74030138 |
| 7 | COPII vesicle coating (GO:0048208) | 5.25144834 |
| 8 | positive regulation of glycoprotein metabolic process (GO:1903020) | 5.04832892 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.02751093 |
| 10 | cellular protein complex localization (GO:0034629) | 5.01208018 |
| 11 | ER overload response (GO:0006983) | 4.99748095 |
| 12 | type B pancreatic cell development (GO:0003323) | 4.74248294 |
| 13 | cornea development in camera-type eye (GO:0061303) | 4.71101973 |
| 14 | sequestering of metal ion (GO:0051238) | 4.66011644 |
| 15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.63475996 |
| 16 | B cell mediated immunity (GO:0019724) | 4.63047107 |
| 17 | astrocyte differentiation (GO:0048708) | 4.59800751 |
| 18 | glandular epithelial cell development (GO:0002068) | 4.59122050 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 4.56031293 |
| 20 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.55481120 |
| 21 | microglial cell activation (GO:0001774) | 4.53740897 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.45426742 |
| 23 | positive thymic T cell selection (GO:0045059) | 4.29626610 |
| 24 | protein maturation by protein folding (GO:0022417) | 4.27273332 |
| 25 | response to peptidoglycan (GO:0032494) | 4.26884507 |
| 26 | glandular epithelial cell differentiation (GO:0002067) | 4.25355146 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.25143079 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.25143079 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 4.25143079 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 4.25143079 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 4.25143079 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.25143079 |
| 33 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.24873767 |
| 34 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.24873767 |
| 35 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.23028472 |
| 36 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.20161246 |
| 37 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.19976755 |
| 38 | insulin secretion (GO:0030073) | 4.16460250 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14822936 |
| 40 | GDP-mannose metabolic process (GO:0019673) | 4.10119264 |
| 41 | cellular extravasation (GO:0045123) | 4.08459378 |
| 42 | detection of other organism (GO:0098543) | 4.05229073 |
| 43 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.04466969 |
| 44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.02123813 |
| 45 | cellular response to exogenous dsRNA (GO:0071360) | 3.99361082 |
| 46 | positive regulation of insulin secretion (GO:0032024) | 3.92854236 |
| 47 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.91881596 |
| 48 | response to prostaglandin E (GO:0034695) | 3.88274995 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.82838992 |
| 50 | positive regulation of glycolytic process (GO:0045821) | 3.82768685 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.82610004 |
| 52 | regulation of insulin secretion (GO:0050796) | 3.81380363 |
| 53 | detection of bacterium (GO:0016045) | 3.81008599 |
| 54 | synaptic vesicle maturation (GO:0016188) | 3.80774705 |
| 55 | vesicle coating (GO:0006901) | 3.79566561 |
| 56 | response to interferon-beta (GO:0035456) | 3.77728364 |
| 57 | intraciliary transport (GO:0042073) | 3.76009464 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.73489954 |
| 59 | peptide hormone processing (GO:0016486) | 3.70754817 |
| 60 | regulation of B cell apoptotic process (GO:0002902) | 3.70101364 |
| 61 | regulation of activation of Janus kinase activity (GO:0010533) | 3.69440184 |
| 62 | auditory receptor cell differentiation (GO:0042491) | 3.68812071 |
| 63 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.65726068 |
| 64 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.65047179 |
| 65 | epithelial cell fate commitment (GO:0072148) | 3.63187163 |
| 66 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.62999436 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.61988154 |
| 68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.60336219 |
| 69 | regulation of glucokinase activity (GO:0033131) | 3.60005046 |
| 70 | regulation of hexokinase activity (GO:1903299) | 3.60005046 |
| 71 | deoxyribonucleotide catabolic process (GO:0009264) | 3.59475173 |
| 72 | positive regulation of antigen processing and presentation (GO:0002579) | 3.56563469 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.54962392 |
| 74 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.50750030 |
| 75 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.50690200 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 3.50384950 |
| 77 | B cell receptor signaling pathway (GO:0050853) | 3.48801288 |
| 78 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.48565484 |
| 79 | lactate metabolic process (GO:0006089) | 3.48262343 |
| 80 | regulation of oxidative phosphorylation (GO:0002082) | 3.46905737 |
| 81 | deoxyribose phosphate catabolic process (GO:0046386) | 3.45746515 |
| 82 | regulation of peptide hormone secretion (GO:0090276) | 3.45551487 |
| 83 | neutrophil activation (GO:0042119) | 3.43318914 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.41292207 |
| 85 | regulation of peptide secretion (GO:0002791) | 3.40787274 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 3.40427014 |
| 87 | response to gravity (GO:0009629) | 3.39577895 |
| 88 | leukocyte degranulation (GO:0043299) | 3.38562100 |
| 89 | histamine secretion (GO:0001821) | 3.38127285 |
| 90 | imidazole-containing compound metabolic process (GO:0052803) | 3.37063951 |
| 91 | mast cell activation (GO:0045576) | 3.36505089 |
| 92 | cellular response to ATP (GO:0071318) | 3.34577420 |
| 93 | single strand break repair (GO:0000012) | 3.34343574 |
| 94 | positive T cell selection (GO:0043368) | 3.34297684 |
| 95 | myeloid leukocyte mediated immunity (GO:0002444) | 3.31191942 |
| 96 | negative regulation of phagocytosis (GO:0050765) | 3.30566297 |
| 97 | protein polyglutamylation (GO:0018095) | 3.29599060 |
| 98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28886964 |
| 99 | protein retention in ER lumen (GO:0006621) | 3.28494608 |
| 100 | macrophage activation (GO:0042116) | 3.27172851 |
| 101 | regulation of mast cell degranulation (GO:0043304) | 3.26396899 |
| 102 | regulation of DNA methylation (GO:0044030) | 3.24999205 |
| 103 | neutrophil mediated immunity (GO:0002446) | 3.23891508 |
| 104 | negative regulation of B cell apoptotic process (GO:0002903) | 3.22779754 |
| 105 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.21563723 |
| 106 | negative regulation of catecholamine secretion (GO:0033604) | 3.21148829 |
| 107 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.20010071 |
| 108 | positive regulation of interferon-alpha production (GO:0032727) | 3.19651956 |
| 109 | detection of external biotic stimulus (GO:0098581) | 3.19562042 |
| 110 | positive regulation of gastrulation (GO:2000543) | 3.19294863 |
| 111 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.19181445 |
| 112 | peptide catabolic process (GO:0043171) | 3.17004382 |
| 113 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.16914242 |
| 114 | response to host immune response (GO:0052572) | 3.16197826 |
| 115 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.16197826 |
| 116 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.15438775 |
| 117 | sensory perception of smell (GO:0007608) | 3.14953207 |
| 118 | positive regulation of peptide hormone secretion (GO:0090277) | 3.13601531 |
| 119 | detection of calcium ion (GO:0005513) | 3.13228878 |
| 120 | histone arginine methylation (GO:0034969) | 3.11659397 |
| 121 | regulation of helicase activity (GO:0051095) | 3.11654466 |
| 122 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10020749 |
| 123 | regulation of interferon-alpha production (GO:0032647) | 3.09602934 |
| 124 | ether lipid metabolic process (GO:0046485) | 3.07860458 |
| 125 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07321569 |
| 126 | positive regulation of mast cell degranulation (GO:0043306) | 3.07321569 |
| 127 | regulation of gamma-delta T cell activation (GO:0046643) | 3.07017789 |
| 128 | autophagic vacuole fusion (GO:0000046) | 3.05531477 |
| 129 | left/right axis specification (GO:0070986) | 3.05381981 |
| 130 | negative regulation of interleukin-12 production (GO:0032695) | 3.04990382 |
| 131 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.04217233 |
| 132 | mast cell degranulation (GO:0043303) | 3.02830197 |
| 133 | mast cell activation involved in immune response (GO:0002279) | 3.02830197 |
| 134 | negative regulation of muscle hypertrophy (GO:0014741) | 3.01394936 |
| 135 | catechol-containing compound biosynthetic process (GO:0009713) | 3.00759812 |
| 136 | catecholamine biosynthetic process (GO:0042423) | 3.00759812 |
| 137 | positive regulation of peptide secretion (GO:0002793) | 3.00535559 |
| 138 | regulation of antigen processing and presentation (GO:0002577) | 2.99950888 |
| 139 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99289217 |
| 140 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98453675 |
| 141 | protein complex localization (GO:0031503) | 2.98189100 |
| 142 | activation of Rac GTPase activity (GO:0032863) | 2.97212051 |
| 143 | purine nucleotide salvage (GO:0032261) | 2.96185624 |
| 144 | regulation of hormone secretion (GO:0046883) | 2.96049325 |
| 145 | regulation of germinal center formation (GO:0002634) | 2.93743714 |
| 146 | detection of biotic stimulus (GO:0009595) | 2.91976987 |
| 147 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.91857906 |
| 148 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.90808968 |
| 149 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.90713898 |
| 150 | Peyers patch development (GO:0048541) | 2.90713898 |
| 151 | granulocyte activation (GO:0036230) | 2.89501226 |
| 152 | neuron fate specification (GO:0048665) | 2.88609109 |
| 153 | organelle membrane fusion (GO:0090174) | 2.88490074 |
| 154 | regulation of peptide transport (GO:0090087) | 2.87829015 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 2.85191187 |
| 156 | adaptation of signaling pathway (GO:0023058) | 2.84712010 |
| 157 | cellular response to interferon-beta (GO:0035458) | 2.84599928 |
| 158 | response to prostaglandin (GO:0034694) | 2.84583357 |
| 159 | somite rostral/caudal axis specification (GO:0032525) | 2.81930308 |
| 160 | diol metabolic process (GO:0034311) | 2.81178482 |
| 161 | nucleoside diphosphate catabolic process (GO:0009134) | 2.79011051 |
| 162 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78969879 |
| 163 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.78758417 |
| 164 | negative regulation of norepinephrine secretion (GO:0010700) | 2.78606536 |
| 165 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.77732515 |
| 166 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77020065 |
| 167 | sphingosine metabolic process (GO:0006670) | 2.75126915 |
| 168 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75106270 |
| 169 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.74582283 |
| 170 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73893071 |
| 171 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.73713995 |
| 172 | pharyngeal system development (GO:0060037) | 2.73070108 |
| 173 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.72221697 |
| 174 | peptide hormone secretion (GO:0030072) | 2.71617206 |
| 175 | renal absorption (GO:0070293) | 2.71118253 |
| 176 | growth hormone receptor signaling pathway (GO:0060396) | 2.70730793 |
| 177 | regulation of leukocyte degranulation (GO:0043300) | 2.70084048 |
| 178 | aggressive behavior (GO:0002118) | 2.69978380 |
| 179 | nucleotide transmembrane transport (GO:1901679) | 2.69835770 |
| 180 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.69742064 |
| 181 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.69537679 |
| 182 | sphingoid metabolic process (GO:0046519) | 2.68394912 |
| 183 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.67642506 |
| 184 | cell wall macromolecule metabolic process (GO:0044036) | 2.65427530 |
| 185 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65399638 |
| 186 | response to host (GO:0075136) | 2.65399638 |
| 187 | response to host defenses (GO:0052200) | 2.65399638 |
| 188 | regulation of thymocyte apoptotic process (GO:0070243) | 2.65139538 |
| 189 | negative regulation of cell killing (GO:0031342) | 2.65051263 |
| 190 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.65051263 |
| 191 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64882124 |
| 192 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63551240 |
| 193 | neuron fate determination (GO:0048664) | 2.62486387 |
| 194 | response to hexose (GO:0009746) | 2.61928631 |
| 195 | cellular response to interferon-gamma (GO:0071346) | 2.61797357 |
| 196 | cell wall macromolecule catabolic process (GO:0016998) | 2.61242109 |
| 197 | negative regulation of T cell apoptotic process (GO:0070233) | 2.61222680 |
| 198 | positive regulation of interferon-beta production (GO:0032728) | 2.60877169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.28332679 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.13531436 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.89709299 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.33150020 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66270703 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.33393490 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.18478714 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03118290 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.88075068 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.85469615 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82666750 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79985844 |
| 13 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.72266625 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.69537319 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.59713599 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.54513856 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52802569 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.50417906 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43879169 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34258979 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33462480 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.33449176 |
| 23 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.15380039 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14661880 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08932017 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.00753224 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99792197 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96783614 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.95621326 |
| 30 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.90145404 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88938319 |
| 32 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.87112258 |
| 33 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.86960164 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86425918 |
| 35 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.86419385 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.80393367 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79204651 |
| 38 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.78159966 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.76448677 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75799764 |
| 41 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.75061863 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.73148310 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72452994 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.71210539 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69650587 |
| 46 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.67733721 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.67359259 |
| 48 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66102931 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63163737 |
| 50 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.61695655 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60920304 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60805190 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57901267 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52831230 |
| 55 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.52532234 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52025069 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51476708 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49090091 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48346716 |
| 60 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47325552 |
| 61 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.46851732 |
| 62 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.46652687 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45995622 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44025926 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43491244 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43270279 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43270279 |
| 68 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.39343641 |
| 69 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38595201 |
| 70 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38206997 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35500278 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35498729 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33941141 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.33091400 |
| 75 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.32372202 |
| 76 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.32253202 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31324509 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27273978 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27102540 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26445416 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.25923055 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25164503 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23530704 |
| 84 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23242357 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.22726854 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22613218 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22352071 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21734280 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20607633 |
| 90 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19973075 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19830269 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19810147 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19138212 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18577653 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18237112 |
| 96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17075165 |
| 97 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15189188 |
| 98 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.13536327 |
| 99 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12710069 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12006735 |
| 101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11914128 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11706314 |
| 103 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11299968 |
| 104 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11235374 |
| 105 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11056537 |
| 106 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10250209 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10205491 |
| 108 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09466050 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09119633 |
| 110 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07880718 |
| 111 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06020340 |
| 112 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05653401 |
| 113 | MAF_26560356_Chip-Seq_TH1_Human | 1.04040270 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03876637 |
| 115 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03343452 |
| 116 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02716052 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02304533 |
| 118 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.01389077 |
| 119 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.00376673 |
| 120 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00219008 |
| 121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00107115 |
| 122 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.99424048 |
| 123 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98912674 |
| 124 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98859795 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98778679 |
| 126 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.98703920 |
| 127 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98543908 |
| 128 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.98097161 |
| 129 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98016665 |
| 130 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98003253 |
| 131 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97583342 |
| 132 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97364711 |
| 133 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96790106 |
| 134 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95919424 |
| 135 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.95515868 |
| 136 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95144441 |
| 137 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.94843213 |
| 138 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.94494118 |
| 139 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.94333720 |
| 140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94274182 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.94265135 |
| 142 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.94207010 |
| 143 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.94207010 |
| 144 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94122293 |
| 145 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.94027828 |
| 146 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93572442 |
| 147 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93189952 |
| 148 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.93109070 |
| 149 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92649296 |
| 150 | P300_27268052_Chip-Seq_Bcells_Human | 0.92545915 |
| 151 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92539163 |
| 152 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92336043 |
| 153 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92032014 |
| 154 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90838182 |
| 155 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90721709 |
| 156 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.90595808 |
| 157 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90458074 |
| 158 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.90230337 |
| 159 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88970193 |
| 160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88877631 |
| 161 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.88835851 |
| 162 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88650959 |
| 163 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88008997 |
| 164 | EWS_26573619_Chip-Seq_HEK293_Human | 0.87797053 |
| 165 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87514387 |
| 166 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87465786 |
| 167 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87037293 |
| 168 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86932778 |
| 169 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86447892 |
| 170 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.86425335 |
| 171 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86337183 |
| 172 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85638307 |
| 173 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84803480 |
| 174 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84533556 |
| 175 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83830295 |
| 176 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82983769 |
| 177 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82983769 |
| 178 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82956326 |
| 179 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.82802808 |
| 180 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82625679 |
| 181 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82509488 |
| 182 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.82156886 |
| 183 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82011240 |
| 184 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81916449 |
| 185 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81586275 |
| 186 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.81535843 |
| 187 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81290865 |
| 188 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.80702404 |
| 189 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80662659 |
| 190 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80506441 |
| 191 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.80400668 |
| 192 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80246183 |
| 193 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79631847 |
| 194 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78905121 |
| 195 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.78178530 |
| 196 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78097686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 5.51923389 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.76287250 |
| 3 | MP0004043_abnormal_pH_regulation | 3.85554469 |
| 4 | MP0000678_abnormal_parathyroid_gland | 3.66519184 |
| 5 | MP0003724_increased_susceptibility_to | 3.62781592 |
| 6 | MP0002693_abnormal_pancreas_physiology | 3.39411881 |
| 7 | MP0001944_abnormal_pancreas_morphology | 3.24348988 |
| 8 | MP0005464_abnormal_platelet_physiology | 3.11804059 |
| 9 | MP0002909_abnormal_adrenal_gland | 3.10773488 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.80717277 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.80112284 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.80103838 |
| 13 | MP0003195_calcinosis | 2.73214089 |
| 14 | MP0004270_analgesia | 2.71622130 |
| 15 | MP0005671_abnormal_response_to | 2.69173462 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.68901359 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.67491023 |
| 18 | MP0001800_abnormal_humoral_immune | 2.63589335 |
| 19 | MP0002419_abnormal_innate_immunity | 2.60861679 |
| 20 | MP0002277_abnormal_respiratory_mucosa | 2.56951956 |
| 21 | MP0008789_abnormal_olfactory_epithelium | 2.56468052 |
| 22 | MP0002396_abnormal_hematopoietic_system | 2.46540015 |
| 23 | MP0003436_decreased_susceptibility_to | 2.46383334 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.40206386 |
| 25 | MP0005220_abnormal_exocrine_pancreas | 2.37318209 |
| 26 | MP0002723_abnormal_immune_serum | 2.31566863 |
| 27 | MP0002452_abnormal_antigen_presenting | 2.30680007 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 2.29035628 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.27094495 |
| 30 | MP0009785_altered_susceptibility_to | 2.26903944 |
| 31 | MP0002160_abnormal_reproductive_system | 2.26460697 |
| 32 | MP0001819_abnormal_immune_cell | 2.24211681 |
| 33 | MP0000013_abnormal_adipose_tissue | 2.22485035 |
| 34 | MP0003303_peritoneal_inflammation | 2.22401801 |
| 35 | MP0005025_abnormal_response_to | 2.21070607 |
| 36 | MP0005387_immune_system_phenotype | 2.14328967 |
| 37 | MP0001790_abnormal_immune_system | 2.14328967 |
| 38 | MP0005310_abnormal_salivary_gland | 2.13943788 |
| 39 | MP0003252_abnormal_bile_duct | 2.02819024 |
| 40 | MP0005257_abnormal_intraocular_pressure | 2.02185836 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.95866613 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.94684862 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.93909376 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.93909376 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.90422297 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 1.90125619 |
| 47 | MP0003283_abnormal_digestive_organ | 1.85005424 |
| 48 | MP0002398_abnormal_bone_marrow | 1.83691516 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.83518919 |
| 50 | MP0003879_abnormal_hair_cell | 1.80845153 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.80545565 |
| 52 | MP0005394_taste/olfaction_phenotype | 1.78333169 |
| 53 | MP0005499_abnormal_olfactory_system | 1.78333169 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.76713414 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.76390371 |
| 56 | MP0006082_CNS_inflammation | 1.74557090 |
| 57 | MP0000716_abnormal_immune_system | 1.74457933 |
| 58 | MP0001485_abnormal_pinna_reflex | 1.73581787 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.73493326 |
| 60 | MP0003787_abnormal_imprinting | 1.70614391 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.69447846 |
| 62 | MP0002928_abnormal_bile_duct | 1.67396885 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 1.67271196 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.66689837 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.64248163 |
| 66 | MP0009764_decreased_sensitivity_to | 1.62915054 |
| 67 | MP0001984_abnormal_olfaction | 1.61329516 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.61103947 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.59450779 |
| 70 | MP0005389_reproductive_system_phenotype | 1.59303941 |
| 71 | MP0002006_tumorigenesis | 1.56457845 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.55960688 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.54091599 |
| 74 | MP0005058_abnormal_lysosome_morphology | 1.53869351 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.53023780 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.52942807 |
| 77 | MP0000613_abnormal_salivary_gland | 1.48928535 |
| 78 | MP0002405_respiratory_system_inflammati | 1.48782462 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.47701313 |
| 80 | MP0009278_abnormal_bone_marrow | 1.47258987 |
| 81 | MP0002722_abnormal_immune_system | 1.47039319 |
| 82 | MP0002429_abnormal_blood_cell | 1.43353927 |
| 83 | MP0010155_abnormal_intestine_physiology | 1.43235254 |
| 84 | MP0008004_abnormal_stomach_pH | 1.42922532 |
| 85 | MP0003300_gastrointestinal_ulcer | 1.40694238 |
| 86 | MP0003866_abnormal_defecation | 1.38916595 |
| 87 | MP0005646_abnormal_pituitary_gland | 1.37652864 |
| 88 | MP0008469_abnormal_protein_level | 1.37380952 |
| 89 | MP0003763_abnormal_thymus_physiology | 1.34098298 |
| 90 | MP0000015_abnormal_ear_pigmentation | 1.32309447 |
| 91 | MP0008961_abnormal_basal_metabolism | 1.32272045 |
| 92 | MP0001756_abnormal_urination | 1.28949266 |
| 93 | MP0000685_abnormal_immune_system | 1.27124767 |
| 94 | MP0003122_maternal_imprinting | 1.27083898 |
| 95 | MP0002896_abnormal_bone_mineralization | 1.26941631 |
| 96 | MP0003075_altered_response_to | 1.21908742 |
| 97 | MP0001853_heart_inflammation | 1.18770307 |
| 98 | MP0002132_abnormal_respiratory_system | 1.18287058 |
| 99 | MP0001533_abnormal_skeleton_physiology | 1.18230294 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 1.17651732 |
| 101 | MP0002938_white_spotting | 1.17600788 |
| 102 | MP0002233_abnormal_nose_morphology | 1.14022148 |
| 103 | MP0008995_early_reproductive_senescence | 1.13734123 |
| 104 | MP0001502_abnormal_circadian_rhythm | 1.12860169 |
| 105 | MP0000372_irregular_coat_pigmentation | 1.12758670 |
| 106 | MP0002751_abnormal_autonomic_nervous | 1.08321057 |
| 107 | MP0000703_abnormal_thymus_morphology | 1.06848487 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 1.02916230 |
| 109 | MP0003953_abnormal_hormone_level | 1.00544910 |
| 110 | MP0005647_abnormal_sex_gland | 0.99280165 |
| 111 | MP0008872_abnormal_physiological_respon | 0.97948929 |
| 112 | MP0002177_abnormal_outer_ear | 0.96401460 |
| 113 | MP0002734_abnormal_mechanical_nocicepti | 0.96024958 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.94110648 |
| 115 | MP0003890_abnormal_embryonic-extraembry | 0.93656297 |
| 116 | MP0002557_abnormal_social/conspecific_i | 0.93295060 |
| 117 | MP0001188_hyperpigmentation | 0.92883419 |
| 118 | MP0000579_abnormal_nail_morphology | 0.91021826 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.90991667 |
| 120 | MP0001849_ear_inflammation | 0.90660920 |
| 121 | MP0003868_abnormal_feces_composition | 0.89959736 |
| 122 | MP0004134_abnormal_chest_morphology | 0.88853332 |
| 123 | MP0003172_abnormal_lysosome_physiology | 0.88629387 |
| 124 | MP0005365_abnormal_bile_salt | 0.86457591 |
| 125 | MP0005448_abnormal_energy_balance | 0.85607047 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.85406491 |
| 127 | MP0003646_muscle_fatigue | 0.85371842 |
| 128 | MP0004947_skin_inflammation | 0.83730585 |
| 129 | MP0000462_abnormal_digestive_system | 0.83677249 |
| 130 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83179332 |
| 131 | MP0002733_abnormal_thermal_nociception | 0.83014734 |
| 132 | MP0003828_pulmonary_edema | 0.82096716 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.82063407 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.81065324 |
| 135 | MP0002019_abnormal_tumor_incidence | 0.80778545 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.80578795 |
| 137 | MP0004133_heterotaxia | 0.79630993 |
| 138 | MP0009333_abnormal_splenocyte_physiolog | 0.79600569 |
| 139 | MP0006276_abnormal_autonomic_nervous | 0.79200352 |
| 140 | MP0005334_abnormal_fat_pad | 0.78455132 |
| 141 | MP0000049_abnormal_middle_ear | 0.78354275 |
| 142 | MP0006036_abnormal_mitochondrial_physio | 0.77527400 |
| 143 | MP0001299_abnormal_eye_distance/ | 0.77052457 |
| 144 | MP0003718_maternal_effect | 0.75554177 |
| 145 | MP0009763_increased_sensitivity_to | 0.74748406 |
| 146 | MP0005166_decreased_susceptibility_to | 0.72903445 |
| 147 | MP0000470_abnormal_stomach_morphology | 0.72868041 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.72675652 |
| 149 | MP0006035_abnormal_mitochondrial_morpho | 0.72216664 |
| 150 | MP0002069_abnormal_eating/drinking_beha | 0.72165582 |
| 151 | MP0000631_abnormal_neuroendocrine_gland | 0.71732797 |
| 152 | MP0008877_abnormal_DNA_methylation | 0.71634841 |
| 153 | MP0005535_abnormal_body_temperature | 0.71450142 |
| 154 | MP0001765_abnormal_ion_homeostasis | 0.71199316 |
| 155 | MP0005408_hypopigmentation | 0.69552207 |
| 156 | MP0008058_abnormal_DNA_repair | 0.69150476 |
| 157 | MP0005452_abnormal_adipose_tissue | 0.68080842 |
| 158 | MP0000538_abnormal_urinary_bladder | 0.67550092 |
| 159 | MP0003786_premature_aging | 0.67052056 |
| 160 | MP0009697_abnormal_copulation | 0.67032341 |
| 161 | MP0004883_abnormal_blood_vessel | 0.66717458 |
| 162 | MP0010329_abnormal_lipoprotein_level | 0.66507761 |
| 163 | MP0002332_abnormal_exercise_endurance | 0.66456431 |
| 164 | MP0002970_abnormal_white_adipose | 0.64580790 |
| 165 | MP0002971_abnormal_brown_adipose | 0.64408450 |
| 166 | MP0002118_abnormal_lipid_homeostasis | 0.64126627 |
| 167 | MP0003959_abnormal_lean_body | 0.62787570 |
| 168 | MP0003634_abnormal_glial_cell | 0.61845335 |
| 169 | MP0003119_abnormal_digestive_system | 0.61177333 |
| 170 | MP0009672_abnormal_birth_weight | 0.61029960 |
| 171 | MP0002184_abnormal_innervation | 0.59766524 |
| 172 | MP0006054_spinal_hemorrhage | 0.59478528 |
| 173 | MP0008260_abnormal_autophagy | 0.58310294 |
| 174 | MP0001968_abnormal_touch/_nociception | 0.58015990 |
| 175 | MP0000604_amyloidosis | 0.57925925 |
| 176 | MP0005410_abnormal_fertilization | 0.57709285 |
| 177 | MP0008873_increased_physiological_sensi | 0.57341603 |
| 178 | MP0000358_abnormal_cell_content/ | 0.56392024 |
| 179 | MP0008775_abnormal_heart_ventricle | 0.54918062 |
| 180 | MP0005266_abnormal_metabolism | 0.54879316 |
| 181 | MP0008007_abnormal_cellular_replicative | 0.54796028 |
| 182 | MP0000516_abnormal_urinary_system | 0.53922861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 5.20424046 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.00262850 |
| 3 | Stomatitis (HP:0010280) | 4.74766109 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.69626294 |
| 5 | Symptomatic seizures (HP:0011145) | 4.63464007 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.61938835 |
| 7 | Agammaglobulinemia (HP:0004432) | 4.45390554 |
| 8 | Hyperglycemia (HP:0003074) | 4.39968782 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.35215544 |
| 10 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.34176276 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.31377750 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.20324624 |
| 13 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.10434531 |
| 14 | Abnormality of B cell number (HP:0010975) | 4.04748334 |
| 15 | Abnormality of the fovea (HP:0000493) | 3.95390466 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.95171271 |
| 17 | Meningitis (HP:0001287) | 3.91042565 |
| 18 | Myositis (HP:0100614) | 3.85442405 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.85207275 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.82520725 |
| 21 | Hypoplasia of the fovea (HP:0007750) | 3.70720457 |
| 22 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.70720457 |
| 23 | Congenital sensorineural hearing impairment (HP:0008527) | 3.58973152 |
| 24 | Abnormality of the prostate (HP:0008775) | 3.53734715 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52850592 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52850592 |
| 27 | Ketoacidosis (HP:0001993) | 3.45264113 |
| 28 | Hypoplasia of the uterus (HP:0000013) | 3.45182311 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.41357051 |
| 30 | Encephalitis (HP:0002383) | 3.39728577 |
| 31 | Granulocytopenia (HP:0001913) | 3.39502755 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.33011914 |
| 33 | Optic neuritis (HP:0100653) | 3.33011914 |
| 34 | B lymphocytopenia (HP:0010976) | 3.29214999 |
| 35 | Decreased circulating renin level (HP:0003351) | 3.22363131 |
| 36 | Eosinophilia (HP:0001880) | 3.19781560 |
| 37 | Obstructive lung disease (HP:0006536) | 3.19020982 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19020982 |
| 39 | Abnormality of macular pigmentation (HP:0008002) | 3.18762369 |
| 40 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.17328649 |
| 41 | Prolonged bleeding time (HP:0003010) | 3.15369737 |
| 42 | Agitation (HP:0000713) | 3.14663872 |
| 43 | Recurrent skin infections (HP:0001581) | 3.12392530 |
| 44 | Orchitis (HP:0100796) | 3.11295128 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 3.08612579 |
| 46 | Dysostosis multiplex (HP:0000943) | 3.08164835 |
| 47 | Chronic bronchitis (HP:0004469) | 3.06323293 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.05812047 |
| 49 | Mucopolysacchariduria (HP:0008155) | 3.05812047 |
| 50 | Petechiae (HP:0000967) | 2.99587126 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.99540068 |
| 52 | Leukocytosis (HP:0001974) | 2.92937018 |
| 53 | Osteomalacia (HP:0002749) | 2.91924354 |
| 54 | Gingival bleeding (HP:0000225) | 2.91693582 |
| 55 | Recurrent viral infections (HP:0004429) | 2.91304274 |
| 56 | Popliteal pterygium (HP:0009756) | 2.90344377 |
| 57 | Epistaxis (HP:0000421) | 2.87925082 |
| 58 | Progressive neurologic deterioration (HP:0002344) | 2.87821815 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.87184476 |
| 60 | Hypokalemia (HP:0002900) | 2.82386463 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.82054511 |
| 62 | Stomach cancer (HP:0012126) | 2.80111731 |
| 63 | Severe combined immunodeficiency (HP:0004430) | 2.75810008 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.74332984 |
| 65 | Enlarged kidneys (HP:0000105) | 2.72180784 |
| 66 | Type I diabetes mellitus (HP:0100651) | 2.71784812 |
| 67 | Hyperparathyroidism (HP:0000843) | 2.71424454 |
| 68 | Hypercortisolism (HP:0001578) | 2.70123419 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68831053 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68831053 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68831053 |
| 72 | Chest pain (HP:0100749) | 2.65188752 |
| 73 | Neuroendocrine neoplasm (HP:0100634) | 2.64170091 |
| 74 | Thrombocytosis (HP:0001894) | 2.63087263 |
| 75 | Vasculitis (HP:0002633) | 2.63008636 |
| 76 | Pancreatic fibrosis (HP:0100732) | 2.62437974 |
| 77 | Thyroiditis (HP:0100646) | 2.61606323 |
| 78 | Hypothermia (HP:0002045) | 2.61484661 |
| 79 | Arterial thrombosis (HP:0004420) | 2.55904038 |
| 80 | Abnormality of eosinophils (HP:0001879) | 2.55437308 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.54278219 |
| 82 | Fair hair (HP:0002286) | 2.53046343 |
| 83 | Urticaria (HP:0001025) | 2.52267108 |
| 84 | Abnormality of T cells (HP:0002843) | 2.51751030 |
| 85 | Hemoptysis (HP:0002105) | 2.48603357 |
| 86 | Episodic fever (HP:0001954) | 2.48111010 |
| 87 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.45113126 |
| 88 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.45113126 |
| 89 | Pheochromocytoma (HP:0002666) | 2.45098224 |
| 90 | Abolished electroretinogram (ERG) (HP:0000550) | 2.44428626 |
| 91 | Growth hormone excess (HP:0000845) | 2.44288757 |
| 92 | Increased IgE level (HP:0003212) | 2.44067316 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42346821 |
| 94 | Cystic liver disease (HP:0006706) | 2.41774964 |
| 95 | Palpitations (HP:0001962) | 2.41064082 |
| 96 | Inflammation of the large intestine (HP:0002037) | 2.40351037 |
| 97 | Acute lymphatic leukemia (HP:0006721) | 2.36794835 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 2.36362134 |
| 99 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.32480930 |
| 100 | 3-Methylglutaconic aciduria (HP:0003535) | 2.32215551 |
| 101 | Attenuation of retinal blood vessels (HP:0007843) | 2.31644809 |
| 102 | Absent eyebrow (HP:0002223) | 2.31434358 |
| 103 | Prostate neoplasm (HP:0100787) | 2.31415581 |
| 104 | Eczematoid dermatitis (HP:0000976) | 2.31002959 |
| 105 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.30128077 |
| 106 | Keratoconjunctivitis (HP:0001096) | 2.26883711 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 2.26644663 |
| 108 | Fatigue (HP:0012378) | 2.26531987 |
| 109 | Trismus (HP:0000211) | 2.25219257 |
| 110 | Malnutrition (HP:0004395) | 2.22986530 |
| 111 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.22945461 |
| 112 | Lip pit (HP:0100267) | 2.22657732 |
| 113 | Retinal dysplasia (HP:0007973) | 2.22501561 |
| 114 | Amelogenesis imperfecta (HP:0000705) | 2.22178584 |
| 115 | Pancreatic cysts (HP:0001737) | 2.21581816 |
| 116 | Pustule (HP:0200039) | 2.20380810 |
| 117 | Skin rash (HP:0000988) | 2.20041326 |
| 118 | Pulmonary embolism (HP:0002204) | 2.18187482 |
| 119 | Amyloidosis (HP:0011034) | 2.18119141 |
| 120 | Abnormality of potassium homeostasis (HP:0011042) | 2.17537499 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 2.17166447 |
| 122 | Dysautonomia (HP:0002459) | 2.16171407 |
| 123 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15932699 |
| 124 | Abnormality of macrophages (HP:0004311) | 2.15823947 |
| 125 | True hermaphroditism (HP:0010459) | 2.13812576 |
| 126 | Cerebral palsy (HP:0100021) | 2.12658844 |
| 127 | Hypoplastic labia majora (HP:0000059) | 2.12628133 |
| 128 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.12489747 |
| 129 | Neoplasm of the adrenal gland (HP:0100631) | 2.12312862 |
| 130 | Hyperactive renin-angiotensin system (HP:0000841) | 2.10196701 |
| 131 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.08181206 |
| 132 | Ketosis (HP:0001946) | 2.07984485 |
| 133 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.07518738 |
| 134 | Late onset (HP:0003584) | 2.07500044 |
| 135 | Molar tooth sign on MRI (HP:0002419) | 2.06804759 |
| 136 | Abnormality of midbrain morphology (HP:0002418) | 2.06804759 |
| 137 | Cellulitis (HP:0100658) | 2.05869947 |
| 138 | Protruding tongue (HP:0010808) | 2.05793345 |
| 139 | Osteomyelitis (HP:0002754) | 2.05190236 |
| 140 | Adrenal overactivity (HP:0002717) | 2.05118082 |
| 141 | Combined immunodeficiency (HP:0005387) | 2.04605674 |
| 142 | Abnormality of the pleura (HP:0002103) | 2.03530991 |
| 143 | Menstrual irregularities (HP:0000858) | 2.03461569 |
| 144 | Dry hair (HP:0011359) | 2.03247311 |
| 145 | Abnormality of male internal genitalia (HP:0000022) | 2.02217871 |
| 146 | IgM deficiency (HP:0002850) | 2.02120771 |
| 147 | Generalized hypopigmentation of hair (HP:0011358) | 2.00989334 |
| 148 | Verrucae (HP:0200043) | 2.00847287 |
| 149 | Papilloma (HP:0012740) | 2.00847287 |
| 150 | Hypergammaglobulinemia (HP:0010702) | 2.00735667 |
| 151 | Absent speech (HP:0001344) | 1.99124043 |
| 152 | Gout (HP:0001997) | 1.97765821 |
| 153 | Viral hepatitis (HP:0006562) | 1.97411727 |
| 154 | Sepsis (HP:0100806) | 1.97252592 |
| 155 | Acute hepatic failure (HP:0006554) | 1.97187963 |
| 156 | Acne (HP:0001061) | 1.97096692 |
| 157 | Gangrene (HP:0100758) | 1.96925301 |
| 158 | Alveolar cell carcinoma (HP:0006519) | 1.96584877 |
| 159 | Abnormality of dental color (HP:0011073) | 1.94675016 |
| 160 | Colitis (HP:0002583) | 1.94274634 |
| 161 | Atonic seizures (HP:0010819) | 1.93294120 |
| 162 | Vacuolated lymphocytes (HP:0001922) | 1.93216840 |
| 163 | Tubulointerstitial nephritis (HP:0001970) | 1.93075834 |
| 164 | Thrombophlebitis (HP:0004418) | 1.92318235 |
| 165 | Increased IgM level (HP:0003496) | 1.92184658 |
| 166 | Constricted visual fields (HP:0001133) | 1.91771070 |
| 167 | Myopathic facies (HP:0002058) | 1.91602409 |
| 168 | Abnormality of lateral ventricle (HP:0030047) | 1.91182347 |
| 169 | Abnormality of T cell number (HP:0011839) | 1.90945804 |
| 170 | Spontaneous abortion (HP:0005268) | 1.90261848 |
| 171 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.89638280 |
| 172 | Decreased central vision (HP:0007663) | 1.87908700 |
| 173 | Cutaneous syndactyly (HP:0012725) | 1.87140102 |
| 174 | Polyneuropathy (HP:0001271) | 1.86228503 |
| 175 | Respiratory difficulties (HP:0002880) | 1.85611640 |
| 176 | Vertigo (HP:0002321) | 1.84939154 |
| 177 | Congenital hepatic fibrosis (HP:0002612) | 1.84869462 |
| 178 | Nephronophthisis (HP:0000090) | 1.84771029 |
| 179 | Polygenic inheritance (HP:0010982) | 1.84740169 |
| 180 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84353475 |
| 181 | Abnormality of the labia majora (HP:0012881) | 1.84223030 |
| 182 | Thoracolumbar scoliosis (HP:0002944) | 1.83271500 |
| 183 | Pancreatitis (HP:0001733) | 1.82348911 |
| 184 | Neutropenia (HP:0001875) | 1.81787476 |
| 185 | Blue irides (HP:0000635) | 1.80697573 |
| 186 | Retinal atrophy (HP:0001105) | 1.80359032 |
| 187 | Congenital glaucoma (HP:0001087) | 1.79797092 |
| 188 | Hyperkalemia (HP:0002153) | 1.78717941 |
| 189 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.78681669 |
| 190 | Abnormal protein glycosylation (HP:0012346) | 1.78681669 |
| 191 | Abnormal glycosylation (HP:0012345) | 1.78681669 |
| 192 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.78681669 |
| 193 | Psychosis (HP:0000709) | 1.75800706 |
| 194 | Gastrointestinal atresia (HP:0002589) | 1.75782567 |
| 195 | Hyperphosphatemia (HP:0002905) | 1.75499053 |
| 196 | Cranial hyperostosis (HP:0004437) | 1.74068711 |
| 197 | Median cleft lip (HP:0000161) | 1.73748204 |
| 198 | Right ventricular cardiomyopathy (HP:0011663) | 1.72454142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 6.25304759 |
| 2 | MAPKAPK3 | 5.42065750 |
| 3 | KIT | 4.05884172 |
| 4 | INSRR | 3.87925993 |
| 5 | ERBB3 | 3.05744952 |
| 6 | DYRK3 | 3.05662280 |
| 7 | BMPR2 | 2.98441559 |
| 8 | PASK | 2.80174070 |
| 9 | CSF1R | 2.64972963 |
| 10 | MAP4K1 | 2.62607885 |
| 11 | MAPKAPK5 | 2.54651090 |
| 12 | FES | 2.52397903 |
| 13 | MAPK15 | 2.51439675 |
| 14 | TEC | 2.40462265 |
| 15 | TRPM7 | 2.33824165 |
| 16 | MAP3K2 | 2.23071457 |
| 17 | MAPK13 | 2.18033559 |
| 18 | MAP3K14 | 1.98876774 |
| 19 | HIPK2 | 1.89477851 |
| 20 | BTK | 1.89403859 |
| 21 | TNK2 | 1.87497842 |
| 22 | MST4 | 1.86390223 |
| 23 | DYRK1B | 1.85335316 |
| 24 | BLK | 1.85244587 |
| 25 | ACVR1B | 1.77358344 |
| 26 | PRKD3 | 1.70672644 |
| 27 | IRAK4 | 1.68793042 |
| 28 | CSNK1A1L | 1.67863855 |
| 29 | BCKDK | 1.66615140 |
| 30 | MAP2K3 | 1.58635789 |
| 31 | DAPK2 | 1.55834357 |
| 32 | MAP4K2 | 1.53367027 |
| 33 | MAP3K13 | 1.53026095 |
| 34 | BMPR1B | 1.51876054 |
| 35 | WNK3 | 1.49253596 |
| 36 | LYN | 1.48588264 |
| 37 | ITK | 1.48533123 |
| 38 | TYK2 | 1.48446552 |
| 39 | FRK | 1.47271660 |
| 40 | RPS6KB2 | 1.45813763 |
| 41 | HCK | 1.44439029 |
| 42 | BCR | 1.44098668 |
| 43 | JAK3 | 1.42342318 |
| 44 | WNK4 | 1.36708933 |
| 45 | IRAK1 | 1.35579940 |
| 46 | GRK6 | 1.34545920 |
| 47 | CSNK1G2 | 1.31304707 |
| 48 | PIK3CG | 1.31000056 |
| 49 | NLK | 1.30541914 |
| 50 | CSNK1G3 | 1.28802296 |
| 51 | TXK | 1.28547009 |
| 52 | EPHA3 | 1.27648337 |
| 53 | CSK | 1.25596314 |
| 54 | NUAK1 | 1.24280693 |
| 55 | ZAP70 | 1.19910692 |
| 56 | RIPK4 | 1.19813299 |
| 57 | IKBKE | 1.14214473 |
| 58 | IKBKB | 1.10830235 |
| 59 | TLK1 | 1.09688468 |
| 60 | NTRK3 | 1.06627059 |
| 61 | LCK | 1.06086660 |
| 62 | MAP3K3 | 1.04330529 |
| 63 | EIF2AK3 | 1.04123578 |
| 64 | MATK | 1.03006648 |
| 65 | CAMKK2 | 1.02120060 |
| 66 | PHKG1 | 1.01023691 |
| 67 | PHKG2 | 1.01023691 |
| 68 | ADRBK2 | 1.00618439 |
| 69 | FLT3 | 0.97328734 |
| 70 | CSNK1G1 | 0.95871389 |
| 71 | CDK9 | 0.95097731 |
| 72 | NTRK1 | 0.93009512 |
| 73 | STK16 | 0.91429027 |
| 74 | RPS6KA2 | 0.88864755 |
| 75 | CDC42BPA | 0.88646772 |
| 76 | PBK | 0.86253755 |
| 77 | CDK19 | 0.84580412 |
| 78 | PAK3 | 0.84179606 |
| 79 | ABL2 | 0.83063840 |
| 80 | ZAK | 0.82725829 |
| 81 | TAF1 | 0.81183762 |
| 82 | STK10 | 0.78788799 |
| 83 | VRK2 | 0.78056674 |
| 84 | VRK1 | 0.76675980 |
| 85 | ERN1 | 0.76477944 |
| 86 | FGR | 0.76201915 |
| 87 | PTK2B | 0.75534611 |
| 88 | MARK3 | 0.72409150 |
| 89 | PTK2 | 0.69896703 |
| 90 | BRAF | 0.67070934 |
| 91 | PDK1 | 0.66425043 |
| 92 | PKN2 | 0.65639014 |
| 93 | MAPK11 | 0.65299767 |
| 94 | TAOK3 | 0.64626840 |
| 95 | GRK1 | 0.62527891 |
| 96 | LRRK2 | 0.62473585 |
| 97 | CDK8 | 0.62001159 |
| 98 | MAP3K11 | 0.61893950 |
| 99 | MAPKAPK2 | 0.60368041 |
| 100 | JAK2 | 0.59619998 |
| 101 | SRPK1 | 0.58264922 |
| 102 | MAP2K7 | 0.57233121 |
| 103 | DYRK2 | 0.56984436 |
| 104 | BRSK1 | 0.56805820 |
| 105 | PRPF4B | 0.56559399 |
| 106 | TAOK1 | 0.55848410 |
| 107 | DAPK1 | 0.53387384 |
| 108 | YES1 | 0.53340913 |
| 109 | GRK7 | 0.53336526 |
| 110 | KDR | 0.52814355 |
| 111 | PDK2 | 0.52700454 |
| 112 | UHMK1 | 0.52611752 |
| 113 | CAMKK1 | 0.52097770 |
| 114 | ADRBK1 | 0.51860967 |
| 115 | EPHA2 | 0.51421904 |
| 116 | TNIK | 0.50233164 |
| 117 | PINK1 | 0.47757774 |
| 118 | PRKCE | 0.46959513 |
| 119 | GRK5 | 0.46626201 |
| 120 | IRAK3 | 0.46355862 |
| 121 | CHUK | 0.45847307 |
| 122 | ABL1 | 0.45588855 |
| 123 | OXSR1 | 0.45176913 |
| 124 | RPS6KB1 | 0.44222992 |
| 125 | FER | 0.43408092 |
| 126 | PRKCI | 0.42596383 |
| 127 | FGFR4 | 0.41285412 |
| 128 | ARAF | 0.40304163 |
| 129 | ILK | 0.38633592 |
| 130 | FGFR2 | 0.38251493 |
| 131 | MAP3K5 | 0.37996147 |
| 132 | IGF1R | 0.37631717 |
| 133 | CAMK2D | 0.37448711 |
| 134 | CAMK2B | 0.36171710 |
| 135 | MAPK12 | 0.36117128 |
| 136 | SYK | 0.35071046 |
| 137 | AKT3 | 0.33654181 |
| 138 | JAK1 | 0.33004601 |
| 139 | CDK3 | 0.32981223 |
| 140 | PRKCQ | 0.32962016 |
| 141 | MARK2 | 0.32692283 |
| 142 | RPS6KA6 | 0.32243599 |
| 143 | NEK9 | 0.32061858 |
| 144 | CDK4 | 0.31322391 |
| 145 | PRKCH | 0.30249665 |
| 146 | PIM1 | 0.29986652 |
| 147 | EGFR | 0.28725915 |
| 148 | RPS6KL1 | 0.28035756 |
| 149 | RPS6KC1 | 0.28035756 |
| 150 | DYRK1A | 0.27532944 |
| 151 | PRKCD | 0.27469622 |
| 152 | FGFR3 | 0.26891919 |
| 153 | TBK1 | 0.26381203 |
| 154 | TGFBR2 | 0.25921570 |
| 155 | NTRK2 | 0.25423276 |
| 156 | PTK6 | 0.24481852 |
| 157 | MAP2K2 | 0.24180696 |
| 158 | PDPK1 | 0.23592908 |
| 159 | EIF2AK2 | 0.23364199 |
| 160 | WNK1 | 0.22630682 |
| 161 | CDK5 | 0.21856376 |
| 162 | CSNK1A1 | 0.21405535 |
| 163 | TGFBR1 | 0.21154172 |
| 164 | PRKG2 | 0.20302400 |
| 165 | EPHB1 | 0.20211976 |
| 166 | PLK2 | 0.19187358 |
| 167 | IRAK2 | 0.18283172 |
| 168 | PRKD2 | 0.18079414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.32993631 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.43063830 |
| 3 | Asthma_Homo sapiens_hsa05310 | 5.02559747 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 4.19564796 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.13404979 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.04403391 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.97392366 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.21599400 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 3.06598772 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.72988631 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.66689325 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.47749177 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.37196516 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.30203290 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.27542340 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19456255 |
| 17 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.10475312 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92691896 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90892257 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.88194530 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.69462633 |
| 22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.61686238 |
| 23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.60072178 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49692148 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49406418 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48009310 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44176021 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.42607452 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39092218 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38917032 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.38810577 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38397637 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35411306 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35056887 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34884786 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31568925 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29403520 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26655484 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23422754 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.22843961 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22628473 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22511864 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.21058425 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.15064178 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13975701 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.09206490 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09177315 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.07785580 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.07143232 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.05096118 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.99692352 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 0.95441846 |
| 53 | Base excision repair_Homo sapiens_hsa03410 | 0.93340340 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.92984451 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92735481 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91919135 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91672440 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90004645 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88980483 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.88520738 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88100636 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87303766 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86390571 |
| 64 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84373853 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82747267 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79419960 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79077265 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78447222 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.77727139 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77574641 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.76743660 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75441599 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75299052 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.73172572 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72462275 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72420982 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70230651 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.69600166 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69458845 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68783126 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67662942 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66864141 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.66807418 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65150066 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65108468 |
| 86 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63222204 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.61362208 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60598096 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60146868 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60007919 |
| 91 | Proteasome_Homo sapiens_hsa03050 | 0.59682576 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57225397 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55844733 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54754342 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54738508 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53783532 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53015245 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51699785 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49755271 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.49359221 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.49220473 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49104501 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47202055 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47011644 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.45961668 |
| 106 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45650254 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45457914 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.45067102 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44978169 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41784526 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41479881 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41136690 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41127419 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40944078 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40826089 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39829727 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38748482 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38326426 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37818536 |
| 120 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37757898 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36467266 |
| 122 | RNA degradation_Homo sapiens_hsa03018 | 0.36450717 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34319766 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32585796 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32568184 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32456332 |
| 127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31748225 |
| 128 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31720717 |
| 129 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31573591 |
| 130 | Peroxisome_Homo sapiens_hsa04146 | 0.30074003 |
| 131 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.29693460 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28784073 |
| 133 | Purine metabolism_Homo sapiens_hsa00230 | 0.28424866 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27730892 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26964328 |
| 136 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.26596558 |
| 137 | Hepatitis B_Homo sapiens_hsa05161 | 0.25756311 |
| 138 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.25634879 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25386454 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25362862 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23550726 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22835390 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21673208 |
| 144 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.19673172 |
| 145 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19262858 |
| 146 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.19233438 |
| 147 | Hepatitis C_Homo sapiens_hsa05160 | 0.19134832 |
| 148 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19057859 |
| 149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16332865 |
| 150 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.14176791 |
| 151 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.13246351 |
| 152 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.12619919 |
| 153 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11405759 |
| 154 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.11404756 |
| 155 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11297919 |
| 156 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.11141504 |
| 157 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10402298 |
| 158 | RNA polymerase_Homo sapiens_hsa03020 | 0.10269473 |
| 159 | Metabolic pathways_Homo sapiens_hsa01100 | 0.09787872 |
| 160 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09495309 |
| 161 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.09299218 |
| 162 | Prostate cancer_Homo sapiens_hsa05215 | 0.08398943 |
| 163 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.08325597 |
| 164 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07382695 |
| 165 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.06903576 |

